Panacea Biotec Ltd receives LoA from CMSS

Panacea Biotec Limited ("the Company") has received a Letter of Award dated April 10, 2026 ("LOA") from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India ("CMSS").

As per the LOA, the Company will supply Diphtheria and Tetanus Vaccine (Absorbed) for Adults and Adolescents IP ("Td Vaccine") in several tranches to CMSS starting from September / October 2026 till November / December 2028 for the value aggregating to INR 20.79 Crore.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 326.00 as compared to the previous close of Rs. 322.05. The total number of shares traded during the day was 5181 in over 230 trades.

The stock hit an intraday high of Rs. 334.55 and intraday low of 324.05. The net turnover during the day was Rs. 1702607.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 Biotechnology LoA CMSS